Amy Mahery
Vermögen: 6 $ am 31.08.2026
Vermögen: 6 $ am 31.08.2026
Amy Mahery is currently an Independent Director at CNS Pharmaceuticals, Inc. since 2024.
Formerly, Ms. Mahery was Chief Commercial Officer at Roivant Sciences Ltd. from 2022 to 2024 and Senior Vice President at EMD Serono, Inc. from 2021 to 2022.
Ms. Mahery completed undergraduate education at Trinity College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.08.2026 | 1 ( 0% ) | 6 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 18.01.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| ROIVANT SCIENCES LTD. | Corporate Officer/Principal | 01.12.2024 |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Corporate Officer/Principal | 01.07.2022 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Roivant Sciences Ltd.
Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Health Technology |
Trinity College
Trinity College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen